Sharemaestro Newsreel

Oppenheimer raises Pulse Biosciences stock price target on AF data

Oppenheimer has increased its price target for Pulse Biosciences (NASDAQ:PLSE) to $35.00 from $30.00, maintaining an Outperform rating, following positive data from the company's nsPFA EFS study on atrial fibrillation. The stock has seen a 142% surge in the past six months and is …

Repligen Reports Q2 2026: Revenue $204M, Adjusted EPS $0.54; Raises FY26 Guidance

Repligen reported strong second-quarter 2026 results with revenue of $204.1 million, a 12% year-over-year increase, and adjusted diluted EPS of $0.54. The company has raised its full-year 2026 guidance for organic revenue growth and adjusted diluted EPS, driven by continued order momentum and portfolio …

Harvard Bioscience to release quarter results before market opens Aug. 11

Harvard Bioscience (Nasdaq: HBIO) announced that it will release its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026. The company will host an earnings conference call at 8:00 a.m. Eastern Time on the same day …

Aptargroup Inc (ATR) Valuation: PE, PB & Fair Value Analysis

Aptargroup Inc (ATR) has a current valuation score of 5.90, placing it 21st out of 21 in the Containers & Packaging industry. Its P/E ratio stands at 22.53, which is significantly below its recent high but above its recent low. The company has not …

EMBC Class Reminder: Embecta Investors are Reminded of the Upcoming August 17 Deadline in the Filed Securities Fraud Class Action to Recover Losses

A securities fraud class action lawsuit has been filed against Embecta Corp. (EMBC) and its executives following a significant stock drop of over 57% on May 5, 2026. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product …

Stifel Adjusts Price Target on Baxter International to $24 From $19, Maintains Hold Rating

Stifel has raised its price target for Baxter International (BAX) to $24 from $19, while maintaining a 'Hold' rating on the stock. This adjustment comes amidst other analyst recommendations and company news, including Goldman Sachs and TD Cowen also adjusting their price targets for …

BioLife Solutions, Inc. (BLFS) Investor Outlook: Navigating Growth with a 4.9% Upside Potential

BioLife Solutions, Inc. (BLFS) is a healthcare company specializing in medical instruments and supplies for cell and gene therapy, with a market cap of $1.46 billion. Despite a current EPS of -0.24 and negative return on equity due to ongoing investments, analysts project a …

Lazard Asset Management LLC Has $77.90 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Lazard Asset Management LLC significantly reduced its stake in DENTSPLY SIRONA Inc. by 23.1% in the first quarter, selling over 2 million shares but still retaining holdings valued at $77.9 million. Despite this, other institutional investors have increased their positions, with institutions collectively owning …

EMBC DEADLINE: The Gross Law Firm Reminds Embecta Corp. Investors of Upcoming Securities Class Action Deadline

The Gross Law Firm is reminding investors of Embecta Corp. (NASDAQ: EMBC) about an upcoming securities class action deadline of August 17, 2026. The lawsuit alleges that Embecta Corp. issued misleading statements regarding its fiscal results, specifically its pen needle business, leading to a …

Biolife Solutions stock hits 52-week high at 32.24 USD

Biolife Solutions stock reached a 52-week high of $32.24, showing a significant 34.8% increase over the past year. The company boasts a 1.56 billion USD market cap, nearly 30% revenue growth, and a "GREAT" financial health score from InvestingPro, though its stock may be …

Bausch + Lomb Launches the EyeGility Inserter Preloaded IOL Delivery System

Bausch + Lomb has launched its new EyeGility Inserter preloaded IOL delivery system in the U.S. This system is designed for use with enVista Aspire and Envy IOLs, offering convenient one-handed operation and smooth delivery with a silicon soft-tipped plunger. The EyeGility Inserter aims …

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX)

This article provides analyst insights for two healthcare companies: InflaRx (IFRX) and Baxter International (BAX). InflaRx received a "Strong Buy" consensus with a significant upside, based on Buy ratings from LifeSci Capital and Oppenheimer. Baxter International holds a "Hold" consensus, with TD Cowen and …

Healthcare Stocks With Less Litigation Risk After The JandJ Talc Settlement

The Johnson & Johnson talc settlement has prompted investors to re-evaluate litigation risk in healthcare stocks. This article examines three large-cap healthcare companies—Cooper Companies (COO), Envista Holdings (NVST), and Centene (CNC)—highlighting their potential appeal due to less direct exposure to significant litigation risks. It …

UBS Initiates STAAR Surgical at Sell With $20 Price Target

UBS has initiated coverage on STAAR Surgical (STAA) with a "Sell" rating and a price target of $20. This rating suggests a negative outlook for the medical equipment company. The article also mentions recent news and analyst updates regarding STAAR Surgical's performance, particularly in …

WST: High Value Injectable Demand And GLP 1 Exposure Will Drive Future Returns

Analysts have raised their target price for West Pharmaceutical Services (WST) to $404, driven by expectations of sustained demand for high-value injectable products and significant exposure to GLP-1 related therapies. While bullish sentiment focuses on strong earnings, product mix, and GLP-1 growth, some cautious …

Align Technology (ALGN) Reports Q2: Everything You Need To Know Ahead Of Earnings

Align Technology (ALGN) is set to announce its Q2 earnings, with analysts expecting a 3.8% year-on-year revenue growth. The company previously exceeded revenue expectations, reporting $1.04 billion, a 6.2% increase from the prior year. Despite recent analyst reconfirmations, Align Technology has missed revenue estimates …

ZTEK|Zentek Ltd|Price:0.542|Chg%:-0.010

This article provides a stock analysis of Zentek Ltd (ZTEK) by TradingKey, highlighting its "Fairly Valued" status and high growth potential with steady revenue growth over the past three years. The company is primarily focused on commercializing its patented anti-microbial coating technology, ZenGUARD, and …

Repligen (NASDAQ:RGEN) Shares Gap Up Following Better-Than-Expected Earnings

Azenta (AZTA) Projected to Release Earnings on Tuesday

AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next

Pulse Biosciences (PLSE) Stock Looks Above Fair Value Today

Align Technology Inc (ALGN) Financial Health: Profitability & Balance Sheet Analysis

Align Technology Inc (ALGN) has a robust financial status with a current financial score of 8.82, ranking 24th in the Healthcare Equipment & Supplies industry. The company reported a 6.21% year-over-year revenue increase to $1.04 billion and a 20.96% year-over-year net profit increase. Despite …

TFX|Teleflex Inc|Price:131.080|Chg%:-1.020

This article provides a comprehensive stock analysis of Teleflex Inc (TFX) by TradingKey, highlighting its "Fairly Valued" status and high institutional ownership. Despite a recent turn to loss, the company is noted for its high and stable dividend payout. Analysts currently rate the stock …

Merit Medical Systems Inc (MMSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Merit Medical Systems Inc (MMSI), focusing on its stock price momentum, support and resistance levels, and various technical indicators and moving averages. While the overall signal from technical indicators is Neutral, moving averages show strong buy signals. …

EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Investors Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements regarding its business and prospects, specifically about its pen needle business, which led to a significant …

Utah Medical Products Inc (UTMD) Valuation: PE, PB & Fair Value Analysis

Utah Medical Products Inc (UTMD) has a current valuation score of 8.45, placing it 93rd out of 199 companies in the Healthcare Equipment & Supplies industry. Its P/E ratio is 20.98, which is slightly below its recent high but significantly above its recent low. …

West Pharmaceutical Services (WST) Is Down 6.0% After Raising 2026 Outlook and Expanding Daikyo Deal

West Pharmaceutical Services (WST) saw its stock fall 6.0% despite reporting stronger Q2 2026 results, raising its full-year 2026 revenue outlook, and expanding its partnership with Daikyo Seiko. The company's investment narrative focuses on the long-term need for high-spec drug packaging, but its rich …

Does Align’s New AI-Powered Workflow Suite Reshape The Bull Case For Align Technology (ALGN)?

Align Technology has introduced new AI-powered tools and workflow enhancements across its Align Digital Platform, integrating features like AI X-ray Insights and 3D facial simulations. These additions aim to deepen Align's integration into dental practices and potentially reinforce clinician reliance on its ecosystem. The …

STAAR Surgical Company Revenue Breakdown – BX:SR3

STAAR Surgical Company (SR3) reported total revenue of 189.82 million CHF last year. Its top-performing segment, Non-consignment, contributed 141.90 million CHF, while "Other" accounted for 74.39 million CHF. The company's financial data is available on TradingView, detailing segments and regional performance.

Aptargroup Inc (ATR) Balance Sheet

This article provides the annual and quarterly balance sheets for Aptargroup Inc (ATR), allowing users to analyze its financial health, fundamentals, and key ratios for liquidity, leverage, and return on equity. It presents detailed financial data for various categories like assets, liabilities, and shareholders' …

Femasys Inc (FEMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Femasys Inc (FEMY), detailing its price momentum score of 5.19, current trading range between resistance at 4.26 and support at 2.38, and a breakdown of key technical indicators and moving averages. While MACD and STOCH indicate neutrality …

Repligen to Acquire BioLife Solutions, Enhancing Cell Therapy Capabilities

Repligen Corporation announced its intent to acquire BioLife Solutions for approximately $1.5 billion, a strategic move aimed at strengthening Repligen's position in the rapidly expanding cell therapy market. The acquisition, valued at $31.00 per share, combines 64% Repligen stock and 36% cash, with the …

Precision Optics Corporation Inc (POCI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Precision Optics Corporation Inc (POCI), highlighting its current valuation score of 8.77 and its rank within the Healthcare Equipment & Supplies industry. It details the company's current P/E ratio, noting its significant deviation from recent highs and …

POCI|Precision Optics Corporation Inc|Price:4.310|Chg%:+0.050

This article provides a detailed financial overview and market analysis of Precision Optics Corporation Inc (POCI). It highlights the company's strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. The report also includes current stock prices, key figures, …

Cooper Companies Inc (COO) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Cooper Companies Inc (COO), noting its current valuation score of 6.74, placing it 172nd out of 199 in the Healthcare Equipment & Supplies industry. It highlights COO's current P/E ratio of 34.65, which is significantly below its …

Align Technology Inc (ALGN) Institutional Confidence

Align Technology Inc (ALGN) has an institutional shareholding score of 10.00, placing it first in its industry. The latest institutional shareholding proportion is 99.80%, indicating a slight quarter-over-quarter decrease. Ruane Cunniff is the largest institutional shareholder, holding 1.27 million shares.